TRAW Traws Pharma, Inc. - Common Stock
$0,57
Preço · Ago 25, 2026
Fundamentais a partir de Ago 14, 2026
Intervalo 52 Semanas
$0–$3
5% of range
Classificação do Analista
HOLD
7 analysts
Preço-Alvo
$1
+75% upside
P/E (TTM)
1.4
ROE
—
Margem de Lucro Líquido
—
TRAW Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.57
Capitalização de Mercado
—
P/E (TTM)
1.4
EPS (TTM)
$0.82
Receita (TTM)
$3M
Rendimento div.
—
ROE
—
Dívida/Capital
—
Intervalo 52 Semanas
$0 – $3
TRAW Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$3M
2016-12-31
→
2025-12-31
EPS
$0.82
2020-12-31
→
2025-12-31
Fluxo de caixa livre
—
2019-12-31
→
2019-12-31
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
TRAW
Mediana de Pares
P/E (TTM)
1.4
23.4
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
TRAW
Mediana de Pares
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
TRAW
Mediana de Pares
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
TRAW
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
1134.5%
—
Revenue CAGR 3Y (CAGR Receita 3A)
131.1%
—
Revenue CAGR 5Y (CAGR Receita 5A)
64.6%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
TRAW
Mediana de Pares
TRAW Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
VENDA
7 analistas
- Compra forte 0 0,0%
- Compra 0 0,0%
- Manter 4 57,1%
- Venda 1 14,3%
- Venda forte 2 28,6%
Preço-alvo de 12 meses
1 analistas · 2026-08-19
Mín
$1.00
Máx
$1.00
Alvo mediano
$1.00
+74,7%
Alvo médio
$1.00
+74,7%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
18.0%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.53 | $-0.75 | 0.22% |
| 31 de Dezembro de 2025 | $0.63 | $-1.25 | 1.9% |
| 31 de Dezembro de 2024 | $95.66 | $-9.74 | 105.4% |
| 30 de Setembro de 2024 | $-8.81 | $-6.25 | -2.6% |
| 31 de Dezembro de 2023 | $-4.75 | $-6.46 | 1.7% |
| 30 de Setembro de 2023 | $-5.75 | $-7.39 | 1.6% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| TRAW | — | 1.4 | 1134.5% | — | — | — |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| CNSP | — | -0.1 | — | — | — | — |
| CURX | $9M | -1.9 | — | — | -73.3% | — |
| SNES | $11M | -1.1 | 19.6% | -287.4% | -77.2% | 62.5% |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2M | $1M | $787.0K | $6M | $11M | $800.0K | |
| R&D Expense | · | · | $11M | $11M | $7M | $17M | $16M | $17M | $19M | $20M | $26M | $49M | |
| SG&A Expense | $9M | $12M | $9M | $8M | $9M | $8M | $8M | $8M | $7M | $9M | $10M | $15M | |
| Operating Expenses | $21M | $143M | $21M | $20M | $17M | $25M | $24M | $25M | $27M | $29M | $35M | $65M | |
| Operating Income | $-18M | $-142M | $-20M | $-20M | $-16M | $-25M | $-22M | $-23M | $-26M | $-24M | $-24M | $-64M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Interest Income | $455.0K | $510.0K | $1M | $651.0K | · | · | · | · | · | · | · | · | |
| Other Non-op | $478.0K | $289.0K | $1M | $663.0K | $12.0K | $48.0K | $143.0K | $1M | $30.0K | $62.0K | $-35.0K | $-52.0K | |
| Pretax Income | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-21M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| Income Tax | · | · | · | · | · | $4.0K | $10.0K | $-124.0K | $13.0K | $14.0K | $16.0K | $19.0K | |
| Net Income | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-22M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| EPS (Basic) | $0.83 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · | |
| Shares (Basic) | 8,228,169 | 1,552,685 | 839,554 | 20,908,235 | 16,832,198 | 11,602,391 | · | · | · | · | · | · | |
| Shares (Diluted) | 8,376,380 | 1,552,685 | 839,554 | 20,908,235 | 16,832,198 | 11,602,391 | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | · | $-22M | $-23M | · | $-24M | $-24M | $-63M |
Balanço Patrimonial 22
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $21M | $39M | · | · | · | · | · | $21M | $20M | $44M | |
| Receivables | $4M | $2M | $18.0K | $29.0K | $28.0K | $37.0K | $98.0K | $35.0K | $59.0K | $31.0K | $2M | $132.0K | |
| Prepaid Expense | $365.0K | $2M | $2M | $561.0K | $332.0K | $722.0K | $650.0K | $760.0K | $820.0K | $2M | $2M | $3M | |
| Other Current Assets | $89.0K | $178.0K | $401.0K | $40.0K | $35.0K | $180.0K | $140.0K | $68.0K | $77.0K | $73.0K | $195.0K | $255.0K | |
| Current Assets | $8M | $25M | $23M | $39M | $55M | $20M | $23M | $18M | $5M | $23M | $23M | $47M | |
| PP&E (Net) | $7.0K | $10.0K | $22.0K | $24.0K | $38.0K | $52.0K | $50.0K | $9.0K | $64.0K | $152.0K | $248.0K | $420.0K | |
| PP&E (Gross) | · | · | $84.0K | $70.0K | $70.0K | $70.0K | $2M | $2M | $2M | $2M | $2M | $3M | |
| Accum. Depreciation | $77.0K | $74.0K | $62.0K | $46.0K | $32.0K | $18.0K | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $104.0K | $1.0K | $1.0K | $1.0K | $10.0K | $150.0K | $150.0K | $149.0K | $12.0K | $12.0K | $12.0K | $12.0K | |
| Total Assets | $11M | $25M | $23M | $39M | $55M | $20M | $24M | $18M | $5M | $23M | $23M | $47M | |
| Accounts Payable | $6M | $8M | $6M | $4M | $3M | $5M | $4M | $4M | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $4M | $3M | $5M | $4M | $4M | · | · | · | · | |
| Current Liabilities | $11M | $12M | $9M | $8M | $6M | $10M | $8M | $8M | $10M | $10M | $8M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1.0K | |
| Total Liabilities | $11M | $57M | $12M | $11M | $9M | $14M | $12M | $13M | $16M | $18M | $13M | $24M | |
| Common Stock | $90.0K | $36.0K | $9.0K | $209.0K | $209.0K | $124.0K | $1M | $57.0K | $8.0K | $68.0K | $25.0K | $217.0K | |
| Retained Earnings | $-640M | $-649M | $-483M | $-464M | $-445M | $-429M | $-403M | $-382M | $-362M | $-338M | $-319M | $-295M | |
| AOCI | $6.0K | $-42.0K | $-23.0K | $-33.0K | $-14.0K | $14.0K | $-18.0K | $-12.0K | $3.0K | $-31.0K | $-22.0K | $-13.0K | |
| Stockholders' Equity | $-629.0K | $-32M | $11M | $28M | $46M | $6M | $12M | $5M | $-12M | $4M | $10M | $23M | |
| Liabilities + Equity | $11M | $25M | $23M | $39M | $55M | $20M | $24M | $18M | $5M | $23M | $23M | $47M | |
| Shares Outstanding | 9,067,774 | 3,650,731 | 840,251 | 20,925,992 | 20,895,563 | 12,396,219 | 111,167,352 | 5,674,220 | 718,078 | 6,759,895 | 2,546,419 | 21,703,173 |
Fluxo de Caixa 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $61.0K | $12.0K | $16.0K | $14.0K | $14.0K | $13.0K | $14.0K | $55.0K | $88.0K | $96.0K | $150.0K | $434.0K | |
| Stock-based Comp | $728.0K | $1M | $1M | $1M | $576.0K | $369.0K | $1M | $1M | $2M | $4M | $4M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | $-137.0K | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $58.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $-390.0K | $-3M | · | $-171.0K | $-11M | $532.0K | |
| Operating Cash Flow | $-18M | $-30M | $-18M | $-16M | $-19M | $-23M | $-21M | $-23M | $-24M | $-16M | $-31M | $-58M | |
| CapEx | $3M | $4M | $14.0K | · | · | $15.0K | $55.0K | · | · | · | · | $228.0K | |
| Investing Cash Flow | $-3M | $-4M | $-14.0K | · | · | $-15.0K | $-55.0K | · | · | · | · | · | |
| Stock Issued | $6M | · | · | · | $55M | $9M | $22M | $35M | · | · | $7M | · | |
| Net Stock Activity | · | · | · | · | · | · | $22M | · | · | · | $7M | · | |
| Financing Cash Flow | $3M | $34M | · | · | $56M | $19M | $27M | $36M | $6M | $17M | · | · | |
| Net Change in Cash | $-18M | $517.0K | $-18M | $-16M | $36M | $-4M | $6M | $13M | $-17M | $2M | $-24M | $-16M | |
| Free Cash Flow | · | · | · | · | · | · | $-21M | · | · | · | · | $-58M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-58M |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | -994.0% | -1895.9% | · | -427.4% | -209.2% | -7968.0% | |
| Net Margin | · | · | · | · | · | · | -985.0% | -1675.3% | · | -354.6% | -209.3% | -7960.3% | |
| Pretax Margin | · | · | · | · | · | · | -984.6% | -1672.1% | · | -354.4% | -209.6% | -7972.0% | |
| EBITDA Margin | · | · | · | · | · | · | -993.4% | -1891.5% | · | -425.7% | -207.9% | -7913.8% | |
| ROA | · | · | · | · | · | · | -103.4% | -179.7% | · | -84.3% | -67.8% | -83.5% | |
| ROE | · | · | · | · | · | · | -777.3% | 652.7% | · | -274.9% | -146.4% | -123.5% | |
| ROIC | · | · | · | · | · | · | -187.6% | -429.6% | · | -552.0% | -239.6% | -280.3% |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | 2.8 | 2.1 | · | 2.3 | 3.0 | 4.6 | |
| Quick Ratio | · | · | · | · | · | · | 0.0 | 0.0 | · | 2.1 | 2.8 | 4.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -31872.0 |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.2 | 0.3 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 32.8 | 26.1 | · | 7.2 | 14.0 | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1134.5% | 0.00% | 0.00% | 0.00% | -2.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 131.1% | 0.00% | -0.73% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2M | $1M | $787.0K | $6M | $11M | $800.0K | |
| Net Income TTM | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-22M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| Market Cap | · | · | · | · | · | · | $15.84B | $4.49B | · | $86.32B | $1.38T | $4.02T | |
| P/E | 1.4 | -0.3 | -0.8 | -17.9 | -66.4 | -81.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | 7256.7 | 3656.1 | · | 15563.5 | 120030.2 | 5020554.3 | |
| P/B | · | · | · | · | · | · | 1368.7 | 833.4 | · | 20087.4 | 137369.3 | 176562.5 | |
| P / Tangible Book | · | · | 36.9 | 12.0 | 28.9 | 5307.3 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | · | -760.5 | -197.8 | · | -5458.5 | -44019.0 | -69671.9 | |
| P / FCF | · | · | · | · | · | · | -758.5 | · | · | · | · | -69397.4 | |
| Earnings Yield | 72.6% | -396.5% | -120.4% | -5.6% | -1.5% | -1.2% | · | · | · | · | · | · |
Demonstração de Resultados 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $3M | $57.0K | $56.0K | $57.0K | $57.0K | $56.0K | $56.0K | $57.0K | $57.0K | $56.0K | $56.0K | $57.0K | |
| R&D Expense | $1M | $5M | · | · | $2M | $3M | · | · | · | $2M | · | $2M | $2M | $4M | $4M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $7M | $7M | $4M | $4M | $5M | $5M | $9M | $123M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Operating Income | $-3M | $-7M | $-7M | $-4M | $-1M | $-5M | $-5M | $-9M | $-123M | $-5M | $-4M | $-5M | $-5M | $-6M | $-6M | $-6M | |
| Other Non-op | $-94.0K | $-2.0K | $14.0K | $96.0K | $188.0K | $180.0K | $-206.0K | $61.0K | $205.0K | $229.0K | $278.0K | $350.0K | $360.0K | $362.0K | $314.0K | $243.0K | |
| Net Income | $-3M | $-7M | $-7M | $-4M | $-915.0K | $21M | $-30M | $-8M | $-123M | $-5M | $-4M | $-5M | $-4M | $-6M | $-5M | $-5M | |
| EPS (Basic) | $-0.16 | $-0.53 | $-0.89 | $-0.34 | $-0.11 | $2.17 | $-7.28 | $-1.49 | $-20.52 | $-5.92 | $-16.45 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.26 | |
| EPS (Diluted) | $-0.16 | $-0.53 | $-0.82 | $-0.34 | $-0.11 | $2.09 | $-7.28 | $-1.49 | $-20.52 | $-5.92 | $-16.45 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.26 | |
| Shares (Basic) | 15,864,041 | 10,640,625 | -13,377,520 | 8,818,859 | 5,820,903 | 6,965,927 | -1,263,013 | 961,530 | 1,012,430 | 841,738 | -41,940,500 | 840,117 | 20,979,766 | 20,960,171 | -41,815,343 | 20,915,408 | |
| Shares (Diluted) | 15,864,041 | 10,640,625 | -13,478,507 | 8,818,859 | 5,820,903 | 7,215,125 | -1,263,013 | 961,530 | 1,012,430 | 841,738 | -41,940,500 | 840,117 | 20,979,766 | 20,960,171 | -41,815,343 | 20,915,408 | |
| EBITDA | $-3M | $-7M | · | $-4M | $-1M | $-5M | · | $-9M | $-123M | $-5M | · | $-5M | $-5M | $-6M | · | $-6M |
Balanço Patrimonial 20
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3M | $2M | $4M | $2M | $1M | $2M | $2M | $2M | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $29.0K | $28.0K | |
| Prepaid Expense | $553.0K | $845.0K | $365.0K | $1M | $966.0K | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $704.0K | $802.0K | $561.0K | $1M | |
| Other Current Assets | $93.0K | $138.0K | $89.0K | $92.0K | $124.0K | $183.0K | $178.0K | $347.0K | $583.0K | $263.0K | $401.0K | $303.0K | $264.0K | $68.0K | $40.0K | $303.0K | |
| Current Assets | $9M | $6M | $8M | $10M | $15M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| PP&E (Net) | $5.0K | $6.0K | $7.0K | $7.0K | $8.0K | $9.0K | $10.0K | $12.0K | $14.0K | $18.0K | $22.0K | $26.0K | $17.0K | $21.0K | $24.0K | $28.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $84.0K | $84.0K | $84.0K | · | $84.0K | $70.0K | $70.0K | · | $70.0K | |
| Accum. Depreciation | · | · | $77.0K | $77.0K | $76.0K | $75.0K | $74.0K | $72.0K | $70.0K | $66.0K | $62.0K | $58.0K | $53.0K | $49.0K | $46.0K | $42.0K | |
| Intangibles | $2M | $2M | $3M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.0K | $1.0K | $104.0K | $240.0K | $244.0K | $198.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Total Assets | $11M | $8M | $11M | $12M | $16M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| Accounts Payable | $6M | $8M | $6M | $5M | $5M | $8M | $8M | $5M | $6M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Accrued Liabilities | $3M | $6M | $5M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | |
| Current Liabilities | $10M | $13M | $11M | $8M | $7M | $10M | $12M | $8M | $10M | $9M | $9M | $10M | $9M | $9M | $8M | $7M | |
| Total Liabilities | $10M | $13M | $11M | $8M | $7M | $13M | $57M | $11M | $13M | $12M | $12M | $13M | $12M | $12M | $11M | $10M | |
| Common Stock | $152.0K | $101.0K | $90.0K | $71.0K | $71.0K | $50.0K | $36.0K | $30.0K | $253.0K | $211.0K | $9.0K | $210.0K | $210.0K | $210.0K | $209.0K | $209.0K | |
| Retained Earnings | $-650M | $-647M | $-640M | $-633M | $-629M | $-628M | $-649M | $-619M | $-611M | $-488M | $-483M | $-478M | $-474M | $-469M | $-464M | $-458M | |
| AOCI | $-5.0K | $-2.0K | $6.0K | $6.0K | $9.0K | $-19.0K | $-42.0K | $-33.0K | $-33.0K | $-30.0K | $-23.0K | $-30.0K | $-28.0K | $-27.0K | $-33.0K | $-61.0K | |
| Stockholders' Equity | $2M | $-5M | $-629.0K | $5M | $8M | $6M | $-32M | $-2M | $-106M | $6M | $11M | $15M | $19M | $23M | $28M | $33M | |
| Liabilities + Equity | $11M | $8M | $11M | $12M | $16M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| Shares Outstanding | 15,264,812 | 10,162,587 | 9,067,774 | 7,131,151 | 7,069,148 | 5,075,390 | 3,650,731 | 3,025,554 | 25,306,509 | 21,085,935 | 840,251 | 21,003,409 | 20,977,625 | 20,969,559 | 20,925,992 | 20,925,992 |
Fluxo de Caixa 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $44.0K | $44.0K | $44.0K | $15.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $4.0K | $4.0K | $5.0K | $4.0K | $3.0K | $4.0K | $3.0K | |
| Stock-based Comp | $816.0K | $634.0K | $327.0K | $135.0K | $105.0K | $161.0K | $334.0K | $343.0K | $380.0K | $333.0K | $332.0K | $360.0K | $273.0K | $336.0K | $330.0K | $305.0K | |
| Amort. of Intangibles | $43.0K | $43.0K | $44.0K | $14.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $4M | · | · | · | $-27M | · | · | · | $222.0K | · | · | · | $893.0K | · | · | |
| Operating Cash Flow | $-8M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-11M | $-10M | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | · | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | · | · | $0 | · | · | · | · | · | |
| Stock Issued | $120.0K | $2M | $2M | $116.0K | $3M | $122.0K | · | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | $122.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $9M | $2M | $158.0K | $-62.0K | $3M | $13.0K | $20M | $0 | · | · | · | · | · | · | · | · | |
| Net Change in Cash | $2M | $-687.0K | $-3M | $-7M | $-3M | $-5M | $16M | $-11M | $496.0K | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M |
Lucratividade 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -45.7% | -9128.1% | · | -14975.4% | -216400.0% | -9307.1% | · | -8928.1% | -8087.7% | -10958.9% | · | -9896.5% | |
| Net Margin | · | · | · | · | -33.5% | 37701.8% | · | -14868.4% | -216040.3% | -8898.2% | · | -8314.0% | -7456.1% | -10312.5% | · | -9470.2% | |
| EBITDA Margin | · | · | · | · | -45.7% | -9126.3% | · | -14975.4% | -216400.0% | -9300.0% | · | -8928.1% | -8087.7% | -10953.6% | · | -9896.5% | |
| ROA | -22.6% | -52.2% | · | -37.1% | -5.3% | 115.4% | · | -47.1% | -501.1% | -18.7% | · | -13.4% | -10.8% | -13.4% | · | -10.4% | |
| ROE | -61.4% | -2063.0% | · | -315.4% | 1.9% | 357.7% | · | -135.8% | 284.3% | -34.5% | · | -19.8% | -14.8% | -17.7% | · | -13.0% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.4 | · | 1.2 | 2.1 | 1.8 | · | 1.1 | 1.9 | 1.9 | · | 2.8 | 3.5 | 3.8 | · | 6.0 | |
| Quick Ratio | 0.4 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.2 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 4.1 | 0.1 | · | 0.1 | 3.3 | 3.2 | · | 2.5 | 2.5 | 2.5 | · | 2.0 |
Avaliação (TTM) 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $3M | $3M | $227.0K | · | $227.0K | $227.0K | $226.0K | · | $227.0K | $227.0K | $226.0K | · | $227.0K | |
| Net Income TTM | $-15M | $10M | · | $8M | $-111M | $-115M | · | $-141M | $-137M | $-20M | · | $-20M | $-19M | $-19M | · | $-17M | |
| Market Cap | $13M | $19M | · | $13M | $10M | $12M | · | $18M | $285M | $532M | · | $373M | $619M | $383M | · | $460M | |
| P/E | -0.7 | 1.6 | · | 12.3 | -0.1 | -0.1 | · | -0.2 | -0.3 | -2.1 | · | -2.8 | -31.7 | -19.6 | · | -25.3 | |
| P/S | 4.4 | 6.4 | · | 4.5 | 3.6 | 51.4 | · | 78.4 | 1254.2 | 2355.8 | · | 1642.3 | 2726.2 | 1693.3 | · | 2028.1 | |
| P/B | 7.6 | -3.5 | · | 2.9 | 1.3 | 1.9 | · | -8.8 | -2.7 | 88.5 | · | 25.7 | 32.7 | 16.7 | · | 13.8 | |
| P / Tangible Book | · | · | · | 6.7 | 1.3 | 1.9 | · | · | · | 88.5 | · | 25.7 | 32.7 | 16.7 | · | 13.8 | |
| P / Cash Flow | · | -7.2 | · | · | · | -2.1 | · | · | · | -120.3 | · | · | · | -84.2 | · | · | |
| Earnings Yield | -135.7% | 60.7% | · | 8.1% | -1353.4% | -1123.5% | · | -570.9% | -286.9% | -47.7% | · | -35.9% | -3.1% | -5.1% | · | -4.0% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $3M | $226.0K | $226.0K | $226.0K | $226.0K |
| Lucro líquido | $9M | $-167M | $-19M | $-19M | $-16M |
| EPS Diluído | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 36 declarantes · $5.0M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 14 (0 vs trimestre anterior) | 6 (-1 vs trimestre anterior) | 9 (+6 vs trimestre anterior) | 8 (+5 vs trimestre anterior) | +2.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $1.014.709 | 1.203.260 | 20,44% | Ações |
| Ally Bridge Group (NY) LLC | $663.033 | 786.236 | 13,36% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $615.609 | 730.000 | 12,40% | Ações |
| ADAR1 Capital Management, LLC | $504.065 | 597.729 | 10,15% | Ações |
| Lynx1 Capital Management LP | $471.801 | 559.470 | 9,50% | Ações |
| Ikarian Capital, LLC | $403.217 | 478.142 | 8,12% | Ações |
| SPHERA FUNDS MANAGEMENT LTD. | $336.043 | 398.486 | 6,77% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $278.231 | 330.049 | 5,60% | Ações |
| Alyeska Investment Group, L.P. | $138.618 | 164.376 | 2,79% | Ações |
| BOOTHBAY FUND MANAGEMENT, LLC | $112.948 | 133.936 | 2,28% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $90.305 | 107.084 | 1,82% | Ações |
| Kynam Capital Management, LP | $71.175 | 84.400 | 1,43% | Ações |
| Dauntless Investment Group, LLC | $67.948 | 80.574 | 1,37% | Ações |
| JANE STREET GROUP, LLC | $59.315 | 70.337 | 1,19% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $45.953 | 54.511 | 0,93% | Ações |
| NORTHERN TRUST CORP | $31.581 | 37.449 | 0,64% | Ações |
| STATE STREET CORP | $21.759 | 25.802 | 0,44% | Ações |
| XTX Topco Ltd | $15.257 | 18.092 | 0,31% | Ações |
| BlackRock, Inc. | $8.383 | 9.941 | 0,17% | Ações |
| Tower Research Capital LLC (TRC) | $4.336 | 5.142 | 0,09% | Ações |
| HUNTINGTON NATIONAL BANK | $3.943 | 4.676 | 0,08% | Ações |
| UBS Group AG | $2.217 | 2.630 | 0,04% | Ações |
| BARCLAYS PLC | $1.642 | 1.947 | 0,03% | Ações |
| SBI Securities Co., Ltd. | $1.451 | 1.721 | 0,03% | Ações |
| Federation des caisses Desjardins du Quebec | $414 | 500 | 0,01% | Ações |
| VANGUARD GROUP INC | $296 | 262 | 0,01% | Ações |
| Vanguard Global Advisers, LLC | $221 | 262 | 0,00% | Ações |
| HRT FINANCIAL LP | $76 | 91.220 | 0,00% | Ações |
| SG Americas Securities, LLC | $12 | 14.524 | 0,00% | Ações |
| Virtu Financial LLC | $11 | 12.579 | 0,00% | Ações |
| Cassaday & Co Wealth Management LLC | $6 | 6 | 0,00% | Ações |
| HARBOUR INVESTMENTS, INC. | $4 | 5 | 0,00% | Ações |
| Integrated Wealth Concepts LLC | $2 | 2 | 0,00% | Ações |
| MORGAN STANLEY | $2 | 2 | 0,00% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $2 | 2 | 0,00% | Ações |
| FMR LLC | $2 | 2 | 0,00% | Ações |
Executivos da empresa 35 insiders · 16 diretores · 18 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Iain D. Dukes | Chief Executive Officer | 9 de Julho de 2026 A | 134.187 | 0 | 0 | $0 |
| Ramesh Kumar | Chief Executive Officer | 26 de Julho de 2018 A | 102.227 | 0 | 0 | $0 |
| Charles Nolan Parker | Chief Financial Officer | 9 de Julho de 2026 A | — | 0 | 0 | $0 |
| Mark Patrick Guerin | CFO | 18 de Junho de 2024 M | 39.255 | 0 | 0 | $0 |
| Ajay Bansal | Chief Financial Officer | 26 de Janeiro de 2016 A | 43.846 | 0 | 0 | $0 |
| Steven M Fruchtman | PRESIDENT, CHIEF EXECUTIVE OFF | 13 de Março de 2024 M | 74.792 | 0 | 0 | $0 |
| Thomas J Mckearn | President, R&D | 26 de Janeiro de 2016 A | 3.333 | 0 | 0 | $0 |
| Nikolay Savchuk | Chief Operating Officer | 9 de Julho de 2026 A | 134.187 | 0 | 0 | $0 |
| Robert Redfield | Chief Medical Officer | 9 de Julho de 2026 A | 97.500 | 0 | 0 | $0 |
| Charles David Pauza | Chief Science Officer Virology | 9 de Julho de 2026 A | 97.500 | 0 | 0 | $0 |
| Victor M Moyo | CHIEF MEDICAL OFFICER | 2 de Outubro de 2023 A | — | 0 | 0 | $0 |
| Mark S. Gelder MD | CHIEF MEDICAL OFFICER | 13 de Março de 2023 A | 10.487 | 0 | 0 | $0 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | 7 de Fevereiro de 2022 A | 24.514 | 0 | 0 | $0 |
| Richard Charles Woodman | Chief Medical Officer | 9 de Julho de 2020 A | — | 0 | 0 | $0 |
| Manoj Maniar | SVP - Product Development | 9 de Julho de 2020 A | 50 | 0 | 0 | $0 |
| James Altland | SVP, Finance & Corp. Develop. | 20 de Dezembro de 2013 A | 10.000 | 0 | 0 | $0 |
| Trafford Clarke | Conselheiro | 9 de Julho de 2026 A | — | 0 | 0 | $0 |
| Mary Teresa Shoemaker | Conselheiro | 9 de Julho de 2026 A | 50.735 | 0 | 0 | $0 |
| John Harold Leaman | Conselheiro | 9 de Julho de 2026 A | — | 0 | 0 | $0 |
| Werner Cautreels | Conselheiro | 9 de Julho de 2026 A | 109.222 | 0 | 0 | $0 |
| Jack E Stover | Conselheiro | 9 de Julho de 2026 A | 6.165 | 0 | 0 | $0 |
| Luba Greenwood | Conselheiro | 16 de Setembro de 2024 A | — | 0 | 0 | $0 |
| Peter Atadja | Conselheiro | 10 de Agosto de 2023 A | — | 0 | 0 | $0 |
| Viren Mehta | Conselheiro | 10 de Agosto de 2023 A | 250.857 | 0 | 0 | $0 |
| Jerome Groopman | Conselheiro | 10 de Agosto de 2023 A | 10.001 | 0 | 0 | $0 |
| James J Marino | Conselheiro | 10 de Agosto de 2023 A | 21.334 | 0 | 0 | $0 |
| Premkumar E Reddy | Conselheiro | 27 de Agosto de 2020 S | 16.683 | 0 | 0 | $0 |
| Michael B Hoffman | Conselheiro | 27 de Agosto de 2020 S | 0 | 0 | 0 | $0 |
| Henry S Bienen | Conselheiro | 29 de Maio de 2018 P | 22.724 | 0 | 0 | $0 |
| Anne Vanlent | Conselheiro | 15 de Junho de 2015 A | — | 0 | 0 | $0 |
| TPAV, LLC | Detentor de 10% | 29 de Dezembro de 2024 P | — | 0 | 0 | $0 |
| TYNDALL CAPITAL PARTNERS L P | Detentor de 10% | 24 de Setembro de 2019 S | 616.389 | 0 | 0 | $0 |
| 683 Capital Management, LLC | Detentor de 10% | 27 de Abril de 2018 P | 14.503.169 | 0 | 0 | $0 |
| Baxter Healthcare SA | Detentor de 10% | 6 de Maio de 2015 J | 0 | 0 | 0 | $0 |
| Michael & Jane Hoffman 2013 Descendants | Detentor de 10% | 21 de Fevereiro de 2014 P | 4.518.275 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 5 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC ×4 declarações | 5 de Maio de 2026 | 11,90% | Emenda | — | SEC |
| Viriom, Inc., Nikolay Savchuk, Iain D. Dukes | 8 de Abril de 2024 | — | Declaração inicial | M&A / venda | SEC |
| 683 Capital Partners, LP, 683 Capital Management, LLC, Ari Zweiman ×5 declarações | 19 de Fevereiro de 2020 | — | Declaração inicial | — | SEC |
| Michael B. Hoffman, Michael and Jane Hoffman 2018 Descendants Trust ×3 declarações | 27 de Julho de 2018 | — | Declaração inicial | Investimento passivo | SEC |
| E. Premkumar Reddy ×2 declarações | 26 de Fevereiro de 2018 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 2 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.